Tuesday, 1 February 2022
For kids under 5, Pfizer's study is giving participants two shots three weeks apart, followed by a third dose at least two months later. The company is testing whether the youngsters produce antibody levels similar to those known to protect teens and young adults.
from Zee News :World https://ift.tt/fSHPqeuQZ